iPSC
A versatile starting
point for any cell type
ENGINEERING CELLS. EXPANDING POSSIBILITIES.
Engineering the next generation
of off-the-shelf cell therapies
A programmable genomic engineering platform for building
functional, scalable iPSC-derived cell therapies.
Recombinase-based
Genome Engineering
Insert, control, and stabilize
therapeutic genetic programs
Engineered iPSCs
Stable, multifunctional
cell lines
Differentiated cells
Immune cells, neurons
and more
Off-the-shelf
cell therapies
For patients who
need them most
ONE PLATFORM. MANY POSSIBILITIES.
The Technology
Programmable genomic
engineering of iPSCs.
- Large genetic programs
- Targeted integration
- Stable expression
- Platform flexibility
Immunotherapy
Engineered immune cells.
Built for solid tumors.
Engineered iPSC-derived immune cells (monocytes/macrophages, NK cells, T cells) with enhanced therapeutic functionality.
★ In collaboration with
Nanyang Technological
University, Singapore
Cell Lines Available
- Cell lines with safety switches (thymidine kinase / iCaspase 9)
- Cell lines with inducible system at a safe harbor site (tetracycline / doxycycline system)
Company
Building the genomic
foundation for cell therapy.
- Our mission & vision
- Our origin
- Our story
- Our location
Partner with Us
Collaborate to bring
transformative therapies
to patients.
- Technology partnerships
- Co-development
- Platform licensing
Opportunities →